Clover Health Investments, Corp. (NASDAQ:CLOV) Shares Purchased by Forum Financial Management LP

Forum Financial Management LP raised its holdings in Clover Health Investments, Corp. (NASDAQ:CLOV) by 33.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 16,077 shares of the company’s stock after acquiring an additional 4,061 shares during the period. Forum Financial Management LP’s holdings in Clover Health Investments were worth $45,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Viewpoint Capital Management LLC grew its position in shares of Clover Health Investments by 96.8% in the second quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company’s stock valued at $38,000 after purchasing an additional 15,000 shares during the period. Jaffetilchin Investment Partners LLC grew its holdings in Clover Health Investments by 30.2% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock valued at $39,000 after buying an additional 11,550 shares during the period. Vanguard Personalized Indexing Management LLC increased its stake in shares of Clover Health Investments by 54.4% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock valued at $42,000 after acquiring an additional 12,104 shares during the last quarter. Realta Investment Advisors purchased a new position in shares of Clover Health Investments during the 3rd quarter worth about $44,000. Finally, Marshall Wace LLP acquired a new stake in shares of Clover Health Investments in the second quarter worth approximately $55,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Clover Health Investments Trading Down 0.2 %

Shares of CLOV opened at $4.32 on Wednesday. Clover Health Investments, Corp. has a twelve month low of $0.61 and a twelve month high of $4.71. The firm has a market capitalization of $2.15 billion, a P/E ratio of -16.00 and a beta of 2.03. The stock’s fifty day simple moving average is $3.39 and its 200 day simple moving average is $2.10.

Clover Health Investments (NASDAQ:CLOV) last released its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.05. The business had revenue of $356.26 million for the quarter, compared to analyst estimates of $338.70 million. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. During the same period in the previous year, the company posted ($0.06) EPS. Sell-side analysts predict that Clover Health Investments, Corp. will post -0.13 earnings per share for the current year.

Analysts Set New Price Targets

Separately, UBS Group assumed coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.